SINT Sintx Technologies, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1269026 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY160.8%
TTM net income YoY5.2%
TTM EPS YoY13.0%
Revenue 3-yr CAGR10.0%
Net income 3-yr CAGR—
Margins
Gross margin59.5%
Operating margin-303.4%
Net margin-281.9%
FCF margin-279.2%
EBITDA margin-295.3%
Returns
ROE-250.4%
ROA-92.1%
ROIC (approx.)—
Asset turnover0.33x
Leverage & solvency
Liabilities / assets61.9%
Debt / equity0.00x
Current ratio1.84x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.96x
Accruals ratio-3.6%
Payout ratio—
Capex / revenue8.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.02M | $2.89M | $2.63M | $1.56M | $606,000 |
| Cost of revenue | $557,000 | $811,000 | $784,000 | $265,000 | $449,000 |
| Gross profit | $461,000 | $2.08M | $1.84M | $1.30M | $157,000 |
| R&D expense | $4.59M | $5.20M | $8.71M | $6.45M | $5.89M |
| SG&A expense | $6.20M | $4.00M | $4.22M | $3.99M | $3.60M |
| Operating income | -$10.72M | -$14.05M | -$13.36M | -$11.34M | -$10.62M |
| Pretax income | -$10.36M | -$11.02M | -$8.26M | -$12.04M | -$9.31M |
| Net income | -$10.36M | -$11.02M | -$8.26M | -$12.04M | -$9.31M |
| EBITDA | -$10.40M | -$13.21M | -$12.45M | -$11.00M | -$10.44M |
| EPS (basic) | -6.16 | -14.87 | -443.47 | -54.67 | -37.70 |
| EPS (diluted) | -6.16 | -15.19 | -624.47 | -60.81 | -39.91 |
| Weighted avg. shares (diluted) | 2.77M | 744,782 | 21,786 | 317,323 | 250,701 |
| Balance sheet | |||||
| Cash & equivalents | $4.14M | $3.60M | $3.34M | $6.25M | $14.27M |
| Inventory | $825,000 | $502,000 | $888,000 | $737,000 | $597,000 |
| Current assets | $5.65M | $4.52M | $5.53M | $7.21M | $15.03M |
| PP&E, net | $476,000 | $922,000 | $4.83M | $5.69M | $4.03M |
| Goodwill | $302,000 | — | — | — | — |
| Intangibles | $142,000 | $16,000 | $21,000 | $26,000 | $31,000 |
| Total assets | $9.51M | $9.41M | $15.37M | $15.77M | $21.84M |
| Current liabilities | $3.73M | $1.98M | $2.91M | $8.08M | $2.75M |
| Short-term debt | $7,000 | $32,000 | $46,000 | $160,000 | $509,000 |
| Long-term debt | — | — | — | $368,000 | — |
| Total debt | — | — | — | $528,000 | — |
| Total liabilities | $6.58M | $5.52M | $6.59M | $10.07M | $4.64M |
| Shareholders' equity | $2.93M | $3.89M | $8.77M | $5.70M | $17.20M |
| Net debt | — | — | — | -$5.72M | — |
| Shares outstanding | 3.97M | 1.34M | 26,603 | 542,145 | 247,106 |
| Cash flow statement | |||||
| Operating cash flow | -$8.57M | -$8.64M | -$14.12M | -$10.26M | -$10.13M |
| Capital expenditure | $185,000 | $690,000 | $530,000 | $1.41M | $3.74M |
| Free cash flow | -$8.76M | -$9.33M | -$14.64M | -$11.67M | -$13.87M |
| Investing cash flow | $913,000 | -$194,000 | -$501,000 | -$1.10M | -$1.66M |
| Financing cash flow | $8.20M | $9.09M | $11.71M | $3.34M | $705,000 |
| Depreciation & amortization | $319,000 | $842,000 | $907,000 | $335,000 | $185,000 |
| Stock-based compensation | $1.39M | $82,000 | $291,000 | $369,000 | $309,000 |
| Share buybacks | $133,000 | — | — | — | — |
Free plan shows the latest 5 periods; Pro shows all 13 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.